2-hydroxypropyl-b-cyclodextrin
This study compared the in-vitro effects of ropivacaine (ropi) in plain, liposomal (MLV) or 2-hydroxypropyl-b-cyclodextrin (HP-b-CD) formulations on cell viability, apoptosis and cytokine (IL-1a, TNF-a, IL-6 and IL-10) release.